Etentamig
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Near Add Your Location
Sorting 20 by
Hope and Healing Cancer Services
Hinsdale, IL
- Accepting patients
- Accepting patients
- Accepting patients
Mayo Clinic (Rochester)
Rochester, MN
- Accepting patients
- Accepting patients
- Accepting patients
Mayo Clinic (Arizona)
Phoenix, AZ
- Accepting patients
- Accepting patients
Northwest Medical Specialties (Tacoma)
NWMS Tacoma — Medical Oncology & Infectious Diseases
Tacoma, WA
- Accepting patients
Maryland Hematology & Oncology. P.A.
Silver Spring, MD
- Not yet accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.